Maxigesic ads found misleading


AFT Pharmaceuticals has engaged in false and misleading conduct in its Maxigesic advertising, the Federal Court has found The Court found that AFT, the manufacturer of the pain relief brand Maxigesic, has engaged in false and misleading conduct in contravention of the Australian Consumer Law when advertising the product. The legal action was instigated by

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous PrEP sees HIV diagnoses drop by a quarter
Next Agenda Setters: Elise Apolloni and the Wanni White Coats